3084. Misbranding of Seconal sodium capsules, thyroid tablets, pentobarbital
sodium capsules, and Metandren Linguets.   U. S. v. Jack Golder (Pine
Lawn Cut Rate Drugs). Plea of guilty.  Fine, $500.   (F. D. C. No. 26738.
Sample Nos. 45743-K, 45950-K, 45953-K to 45955-K, incl.)   -
INFORMATION FILED : October 12,1949, Eastern District of Missouri, against Jack
Golder, trading as Pine Lawn Cut Rate Drugs, at Pine Lawn, Mo.
INTERSTATE SHIPMENT :    Between the approximate dates of October 2, 1947, and
November 13, 1948, from Indianapolis, Ind., Chicago, 111., and Summit, N. J.,
into the State of Missouri, of quantities of Seconal sodium capsules, thyroid
4ablets, pentobarbital sodium capsules, and Metandren Lmguets.
LABEL, WHEN SHIPPED:    "Seconal Sodium 1? grs.," "1 Grain Thyroid Tablets
U. S. P.," "Pentobarbital Sodium Capsules   Yellow   1? grain   TJ. *S. P.," and
"Metandren Linquets   *    *    *   Each Linquet contains 10 mg. of Metandren
(methyltestosterone U. S. P. XIII)."
ALLEGED VIOLATION : On or about January 20, 24, and 26, 1949, while the drugs
were being held for sale after shipment in interstate commerce, the defendant
caused quantities of the drugs to be removed from the containers in which they
had been shipped, to be repacked, and to be sold to various persons without a.
prescription, which acts by the defendant resulted in the repackaged drugs
being misbranded.
NATURE OF CHARGE: Misbranding, r Section 502 (b) (1), the repackaged drugs
failed to bear labels containing the name and place of business of the manu-
facturer, packer, or distributor; Seetion 502 (b) (2*), they bore no label con-
taining an accurate statement of the quantity of the contents; Section 502
(e) (1), they were not designated solely by a name recognized in an official
compendium, and their labels failed to bear the common or usual names of the
drugs; and, Section 502 (f) (1), they bore no labeling containing directions for
use.
Further misbranding, Section 502 (d), the repackaged Seconal sodium
capsules and the repackaged pentobarbital sodium capsules were drugs for use
by man and contained chemical derivatives of barbituric acid, which deriva-
tives had been by the Administrator of the Federal Security Agency, after
investigation, found to be, and by regulations designated as, habit forming;
and the labels of the repackaged drugs failed to bear the name, and quantity
or proportion of such derivatives and in juxtaposition therewith the statement
"Warning-May be habit forming."
DISPOSITION: March 17, 1950. A plea of guilty having been entered,-.the court
imposed a fine of $500.